Structure

InChI Key YNQQEYBLVYAWNX-WLHGVMLRSA-N
Smile CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C/C(=O)O
InChI
InChI=1S/C19H19NOS.C4H4O4/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19;5-3(6)1-2-4(7)8/h2-5,8,11H,6-7,9-10,12H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1+

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H23NO5S
Molecular Weight 425.51
AlogP 4.01
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 0.0
Polar Surface Area 20.31
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 22.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Histamine H1 receptor antagonist ISBN

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dermatitis, Atopic 3 D003876 ClinicalTrials
Conjunctivitis, Allergic 3 D003233 ClinicalTrials
Rhinitis, Allergic, Perennial 3 D012221 ClinicalTrials
Chronic Pain 3 D059350 ClinicalTrials
Fractures, Bone 3 D050723 ClinicalTrials
Dermatitis 3 D003872 ClinicalTrials

Related Entries

MCS

Scaffolds

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Eye disorders
43.36
General disorders and administration site conditions
23.16
Injury, poisoning and procedural complications
7.99
Nervous system disorders
7.18
Skin and subcutaneous tissue disorders
6.58
Immune system disorders
3.38

Cross References

Resources Reference
ChEBI 31750
ChEMBL CHEMBL1633
EPA CompTox DTXSID30892970
FDA SRS HBD503WORO
Guide to Pharmacology 7206
KEGG D08105
PubChem 5282408
SureChEMBL SCHEMBL8809
ZINC ZINC00004351